Allstate Corp Abb Vie Inc. Transaction History

Allstate Corp

$1.02 Billion
Q3 2024

A detailed history of Allstate Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Allstate Corp holds 1,633 shares of ABBV stock, worth $280,271. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,633

Previous 5,856 72.11%

Holding current value

$280,271

Previous $1 Million 67.93%

% of portfolio

0.03%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $691,896 - $841,770	-4,223 Reduced 72.11%	1,633 $322,000
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $7,991 - $9,105	-50 Reduced 0.85%	5,856 $1.07 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $43,481 - $48,970	-316 Reduced 5.08%	5,906 $915,000
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $10.5 Million - $12.1 Million	-72,802 Reduced 92.13%	6,222 $991,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $55,324 - $66,348	400 Added 0.51%	79,024 $12.8 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $8.35 Million - $10.6 Million	-60,668 Reduced 43.55%	78,624 $12 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $923 - $1,146	7 Added 0.01%	139,292 $22.6 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $10.6 Million - $13.4 Million	98,291 Added 239.77%	139,285 $18.9 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $385,487 - $437,585	-3,623 Reduced 8.12%	40,994 $4.42 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $338,776 - $377,416	-3,220 Reduced 6.73%	44,617 $5.03 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $401,834 - $442,371	3,928 Added 8.95%	47,837 $5.18 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $239,377 - $323,184	2,974 Added 7.27%	43,909 $4.71 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $922,501 - $1.08 Million	-10,738 Reduced 20.78%	40,935 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $399,206 - $534,197	5,441 Added 11.77%	51,673 $5.07 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $6.13 Million - $9.29 Million	-94,993 Reduced 67.26%	46,232 $3.52 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $87,926 - $110,014	-1,219 Reduced 0.86%	141,225 $12.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $447,724 - $538,293	7,109 Added 5.25%	142,444 $10.8 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1.41 Million - $1.81 Million	21,515 Added 18.9%	135,335 $9.84 Million
Q1 2019 May 20, 2019	BUY	$77.14 - $90.79 $631,699 - $743,479	8,189 Added 7.75%	113,820 $9.17 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $8.22 Million - $10.1 Million	105,631 New	105,631 $9.74 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account